FDA Accelerated Approval: How will we get drugs that work? NBCC advocates have been excited about the promise of immunotherapy […]
Addressing breast cancer disparities means addressing the upstream causes that shape risk and limit access to care. That includes housing, neighborhood investment, healthcare access, and environmental justice.
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
FDA Accelerated Approval: How will we get drugs that work? NBCC advocates have been excited about the promise of immunotherapy […]
A Closer Look at the DOD Breast Cancer Research Program The Department of Defense (DOD) has operated the peer-reviewed Breast […]
Sign of Progress at the FDA? NBCC has long pushed for drug approvals based on clinically-significant outcomes: meaningful improvements in […]
2021 Legislative and Public Policy Priorities This month, The NBCC Board of Directors met and approved a set of legislative […]
COVID-19 Vaccination and Cancer Are breast cancer patients considered high-risk and given priority for the COVID vaccines? It depends on […]
Early-stage hormone-receptor positive, HER2 negative (HR+/HER2-) breast cancer is the most commonly diagnosed type of breast cancer. While the majority […]
